Prevalence and incidence of systemic lupus erythematosus and associated outcomes in the 2009–2016 US Medicare population
| Autor: | K M Nieman, Y Peng, T Gong, D T Gilbertson, S Li |
|---|---|
| Rok vydání: | 2019 |
| Předmět: |
Aged
80 and over Male Pediatrics medicine.medical_specialty business.industry Incidence Incidence (epidemiology) Comorbidity Medicare United States Age Distribution Cross-Sectional Studies Rheumatology Cause of Death Medicare population Prevalence Humans Lupus Erythematosus Systemic Medicine Female Observational study Sex Distribution business Aged |
| Zdroj: | Lupus. 29:15-26 |
| ISSN: | 1477-0962 0961-2033 |
| DOI: | 10.1177/0961203319888691 |
| Popis: | Objectives We aimed to update data on the prevalence and incidence of systemic lupus erythematosus (SLE) in the Medicare population and describe associated outcomes. Methods This observational study used Medicare 20% random sample data 2007–2016 to estimate SLE prevalence and incidence 2009–2016. The study population included patients aged ≥18 years (stratified by Results The study included > 5 million eligible patients for each year 2009–2016. There were 19,518 (10,898, aged ≥65; 8620, aged Conclusions Prevalence rates steadily increased while incidence was relatively stable 2009–2016. Our data should be interpreted with caution due to our elderly study population. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|